and they did lab tests for sterility, germ contamination, and to measure the amount of semaglutide. The products were purchased and tested between August 2023 and March 2024. The six vendors ...

Outside of the lab, semaglutide was associated with fewer drinks per drinking day and a greater reduction in the number of heavy drinking days over time. Heavy drinking was defined as four or more ...

Researchers also evaluated participants for weight changes, pain, adverse events, and labs. Semaglutide appeared to benefit participants more than the placebo. Almost 63% of participants who ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...

In a controlled lab setting, participants taking semaglutide drank less alcohol. However, outside the lab, their overall drinking days and daily alcohol intake did not change significantly.

Semaglutide, the active ingredient in drugs like Wegovy and Ozempic, can help people lose weight — and a new study says it may also help people quit smoking. In the study, published in the ...

But now there is a shortage of Ozempic and other GLP-1s, which has led to a swell of clones that purport to offer the same benefits and the same key ingredient, semaglutide, at lower prices.

The study, led by neuroscientist Amber Alhadeff and her team, focused on semaglutide, the active ingredient in GLP-1 drugs such as Wegovy and Ozempic. Semaglutide is known to affect brain circuits, ...